TNXP Tonix Pharmaceuticals Holding Corp.

NASDAQ
$9.86

Tonix Pharmaceuticals Holding Corp. (TNXP) is expected to report earnings on November 9, 2026, before the market open. The consensus earnings estimate is a loss of $2.52 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -15.2% since its last earnings release on August 10, 2026.

Tonix Pharmaceuticals Holding Beat Consensus Estimates
Monday, August 10, 2026 · 7:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 9
Monday · 7:00 AM ET
Earnings Whisper
-
vs ($2.52)
Rev est $14.32M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $12.42

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a pharmaceutical company dedicated to the development of novel pharmaceutical products for challenging disorders of the central nervous system.

Sector

Healthcare

Industry

Drug Manufacturers/Other

Held By 2 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.